Hemophilia B Clinical Trials in Tianjin, Tianjin Municipality
7 recruitingTianjin, Tianjin Municipality, China
Showing 1–7 of 7 trials
Recruiting
Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Hemophilia AHemophilia B
Pfizer245 enrolled75 locationsNCT05145127
Recruiting
Phase 3
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Hemophilia AHemophilia B
Pfizer100 enrolled66 locationsNCT05611801
Recruiting
National Longitudinal Cohort of Hematological Diseases
Acute Myeloid LeukemiaMultiple MyelomaMyelodysplastic Syndrome+14 more
Institute of Hematology & Blood Diseases Hospital, China2,300 enrolled1 locationNCT04645199
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China21 enrolled1 locationNCT05641610
Recruiting
Early Phase 1
Safety and Tolerability of VGB-R04 in Patients With Haemophilia B
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China3 enrolled1 locationNCT05152732
Recruiting
Not Applicable
The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China6 enrolled1 locationNCT05630651
Recruiting
Phase 1
Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China9 enrolled1 locationNCT05709288